• nPEC: A Universal Method for Dual-Loaded Liposome Efficiency

  2026-05-03

  This study establishes nanoparticle exclusion HPLC (nPEC) as a universally applicable and accurate method for determining encapsulation efficiency in dual-loaded liposomes, even when hydrophilic and lipophilic drugs differ significantly in their properties. These findings streamline combinatorial drug delivery research and have immediate implications for optimizing antiviral and immune modulation studies.

• Dibutyryl-cAMP, Sodium Salt: Mechanisms and Benchmarks in cA

  2026-05-02

  Dibutyryl-cAMP, sodium salt is a cell-permeable, stable cyclic AMP analog that selectively activates cAMP-dependent signaling, notably protein kinase A. This article details its mechanism, evidentiary support, and optimal workflow parameters for robust cAMP signaling pathway research.

• Capsaicin in Research: Protocol Enhancements and Troubleshoo

  2026-05-02

  Capsaicin ((E)-Capsaicin) is a dual-action research tool that enables precise modulation of TRPV1 ion channels and epigenetic targets. This article delivers stepwise protocols, advanced applications, and actionable troubleshooting insights for maximizing reproducibility in pain, inflammation, and cancer models.

• BV6: Selective IAP Antagonist for Cancer and Endometriosis R

  2026-05-01

  BV6 is a selective IAP antagonist that induces apoptosis in cancer cells and sensitizes them to chemotherapy and radiotherapy. It exhibits a verified IC50 of 7.2 μM in H460 NSCLC cells and reduces cIAP1 and XIAP levels in multiple cell models. Its robust solubility in DMSO and ethanol and validated in vivo activity make it a key research tool for apoptosis and endometriosis studies.

• Berberrubine Modulates Metabolism and Gut Microbiota in NAFL

  2026-04-30

  This article examines the 2022 study by Yang et al., which identified berberrubine—a primary metabolite of berberine—as a potent modulator of glucose and lipid metabolism and gut microbiota in non-alcoholic fatty liver disease (NAFLD) models. The findings highlight berberrubine’s multifaceted mechanism of action and its translational value for metabolic disease research.

• β-Amanitin: Precision Tools for RNA Polymerase II Studies

  2026-04-30

  β-Amanitin unlocks high-specificity inhibition of RNA polymerase II, enabling precise dissection of transcriptional regulation and gene expression workflows. Learn how to optimize experimental protocols and troubleshoot common challenges using APExBIO’s research-grade β-Amanitin for advanced transcriptional and toxicology studies.

• Hoechst 33342: Transforming Nuclear Staining in Cell Biology

  2026-04-29

  Hoechst 33342, a benchmark bis-benzimidazole fluorescent dye, empowers researchers with high-specificity nuclear visualization for live-cell assays and advanced disease models. Thanks to APExBIO’s high-purity supply, workflows from cell cycle analysis to apoptosis detection become more reproducible, quantitative, and interpretable.

• 25-Hydroxycholesterol Drives Immunosuppressive Macrophage Me

  2026-04-29

  Xiao et al. (2024) uncover a lysosomal 25-hydroxycholesterol (25HC)–AMPK axis that metabolically reprograms tumor-associated macrophages (TAMs) toward immunosuppression. By detailing how CH25H-derived 25HC activates AMPKα and STAT6 signaling, the study presents a mechanistic basis for targeting macrophage metabolism to enhance anti-tumor immunity.

• Pentoxifylline Modulates Neonatal Monocyte Hyperinflammation

  2026-04-28

  This study investigates how pentoxifylline (PTX) modulates LPS-induced hyperinflammation in monocytes from preterm infants, revealing strong anti-inflammatory effects via downregulation of TLR4 and key surface markers. Findings highlight age-dependent immune responses and provide a mechanistic basis for PTX's adjunctive use in neonatal sepsis, with implications for pathway-targeted modulation strategies.

• Crizotinib Hydrochloride in Next-Generation Precision Oncolo

  2026-04-28

  Explore how Crizotinib hydrochloride, a potent ALK kinase inhibitor, advances precision oncology by enabling nuanced studies of tumor–stroma interactions and drug resistance using sophisticated assembloid models. This article delivers new insights for optimizing cancer biology research workflows.

• Mapping Metabolite Regulation of TET2 via Biochemical and NM

  2026-04-27

  Zhang et al. present a robust protocol integrating biochemical assays and saturation transfer difference (STD) NMR spectroscopy to quantify metabolite binding and regulatory effects on TET2 dioxygenase. This approach enables precise identification of endogenous TET2 modulators, offering new mechanistic insight into the metabolic-epigenetic interface and supporting reproducible discovery of activators and inhibitors.

• Applied Workflows with 3-Deazaneplanocin (DZNep) in Cancer R

  2026-04-27

  3-Deazaneplanocin (DZNep) from APExBIO empowers precision-targeted epigenetic modulation for cancer and metabolic disease studies, enabling robust protocols for apoptosis induction and cancer stem cell targeting. This guide translates current research, including breast cancer heterogeneity insights, into actionable workflow enhancements and troubleshooting strategies.

• Flavopiridol: Strategic Insights for Translational Cell Cycl

  2026-04-26

  This article delivers a thought-leadership perspective on leveraging Flavopiridol as a pan-CDK inhibitor in translational research, integrating mechanistic understanding, protocol optimization, and future directions for cancer and stem cell models. Emphasizing both biological rationale and workflow practicality, it uniquely bridges ER stress with cell cycle regulation, setting a new standard for experimental design and data reproducibility in the field.

• miR-18a/ALOXE3 Axis: Ferroptosis and Migration in Glioblasto

  2026-04-25

  Yang et al. (2021) reveal that miR-18a enhances glioblastoma progression by downregulating ALOXE3, which suppresses ferroptosis and promotes migration via altered lipid signaling. These insights position the miR-18a/ALOXE3 pathway as a potential therapeutic target and clarify the mechanistic interplay between lipid metabolism and GPCR-mediated cell signaling in GBM.

• EGTA (Egtazic Acid): Precision Calcium Chelation in Cardiac-

  2026-04-24

  Explore the unique role of EGTA (egtazic acid) as a selective calcium chelator in dissecting cardiac vagal neuron pathways and presynaptic/postynaptic signaling. This article offers a deeper, application-focused analysis, leveraging breakthrough insights from electrophysiology and molecular pharmacology.

444 records 19/30 page Previous Next First page 上5页 1617181920 下5页 Last page